LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer
Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor characterized by rapid progression. The mechanisms that lead to a shift from initial therapeutic sensitivity to ultimate therapeutic resistance are poorly understood. Although the SCLC genomic landscape led to the discovery of promi...
Main Authors: | Takanobu Jotatsu, Shigehiro Yagishita, Ken Tajima, Fumiyuki Takahashi, Kaoru Mogushi, Moulid Hidayat, Aditya Wirawan, Ryo Ko, Ryota Kanemaru, Naoko Shimada, Keiko Mitani, Tsuyoshi Saito, Kazuya Takamochi, Kenji Suzuki, Shinji Kohsaka, Shinya Kojima, Hiroshi Mukae, Kazuhiro Yatera, Kazuhisa Takahashi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-03-01
|
Series: | Biochemistry and Biophysics Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580816303235 |
Similar Items
-
Maternally provided LSD1/KDM1A enables the maternal-to-zygotic transition and prevents defects that manifest postnatally
by: Jadiel A Wasson, et al.
Published: (2016-01-01) -
The lasting influence of LSD1 in the blood
by: Sharon YR Dent, et al.
Published: (2013-06-01) -
LSD1/KDM1A, a Gate-Keeper of Cancer Stemness and a Promising Therapeutic Target
by: Panagiotis Karakaidos, et al.
Published: (2019-11-01) -
Histone demethylase Lsd1 represses hematopoietic stem and progenitor cell signatures during blood cell maturation
by: Marc A Kerenyi, et al.
Published: (2013-06-01) -
LSD1/KDM1A inhibitors in clinical trials: advances and prospects
by: Yuan Fang, et al.
Published: (2019-12-01)